DSM buying Amyris Brazil

The Dutch Royal DSM and Emeryville, a company expert in the field of health, nutrition and materials, increased your Alliance, begun in May of that year, with the American biotechnology company Amyris Inc. through the acquisition of Amyris Brazil Ltda for $ $58 million.
With the acquisition of Brotas, Sao Paulo 1, DSM adds to your portfolio a strong biotechnology base and also access to the abundant supply of renewable raw material derived from sugar cane. In addition, the Dutch use your big promise in fermentation plants experience to optimize the operations of the complex.
The partnership between the two companies began in May with the €25 million investment by DSM in Amryris, in Exchange for technological support at strategic points. Until then the two companies have launched a series of products developed in collaboration, such as vitamins and nutritional complexes.
In addition, DSM acquired the intellectual rights on the production technology of farnesene. This hydrocarbon is acquired from sugar cane and is the raw material for the production of lubricants, diesel, biodiesel, cosmetics and detergents. The Brotas 1 plant produces 24000 tons of farnesene.
Currently, the U.S. is building the 2 Springs drive, Campinas-SP. The DMS is committed to continue the supply of materials and other special compounds until the completion of the new facility.